GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Net Margin %

Control Bionics (ASX:CBL) Net Margin % : -115.98% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Control Bionics's Net Income for the six months ended in Dec. 2024 was A$-3.22 Mil. Control Bionics's Revenue for the six months ended in Dec. 2024 was A$2.78 Mil. Therefore, Control Bionics's net margin for the quarter that ended in Dec. 2024 was -115.98%.

The historical rank and industry rank for Control Bionics's Net Margin % or its related term are showing as below:

ASX:CBL' s Net Margin % Range Over the Past 10 Years
Min: -139.29   Med: -109.48   Max: -90.38
Current: -137.22


ASX:CBL's Net Margin % is ranked worse than
81.22% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: 0.11 vs ASX:CBL: -137.22

Control Bionics Net Margin % Historical Data

The historical data trend for Control Bionics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Net Margin % Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Net Margin %
- -90.38 -139.29 -103.61 -115.35

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only -108.97 -98.10 -77.03 -163.05 -115.98

Competitive Comparison of Control Bionics's Net Margin %

For the Medical Devices subindustry, Control Bionics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Control Bionics's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Control Bionics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Control Bionics's Net Margin % falls into.


;
;

Control Bionics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Control Bionics's Net Margin for the fiscal year that ended in Jun. 2024 is calculated as

Net Margin=Net Income (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=-5.914/5.127
=-115.35 %

Control Bionics's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-3.222/2.778
=-115.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Control Bionics  (ASX:CBL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Control Bionics Net Margin % Related Terms

Thank you for viewing the detailed overview of Control Bionics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Control Bionics Business Description

Traded in Other Exchanges
N/A
Address
11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.